SCR-LIP-000747 · Claim · machine-readable JSON →

DXA regional fat measures are used in lipedema studies as descriptive variables or as proxy definitions of a lipedema-like phenotype.

General proposition consolidated from 3 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
4 source(s) · by Amato
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20252026The Lipedema Phenotype is Inversely Associated with Celiac Disease Autoimmunity: Testing the Immunological Shield Hypothesis in NHANES — Amato et al. (2025) · consistentJCEM Case Reports, 2026, 4, luag018 (2026) · consistentUnveiling kinesiophobia: A hidden challenge (2026) · consistentExploring the Immunological Shield Hypothesis: A Population-Based Exploration of Phenotypic Divergence Between Lipedema and Celiac Disease Autoimmunity — Amato et al. (2026) · consistent

Evidence (4)

Context (PECO)

Populationsingle woman with lipedema
Conditionlipedema
ExposureDXA body composition assessment
Outcomeregional fat masses and android-to-gynoid fat ratio
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log